# Lexeo Therapeutics, Inc.: Form 8-K, filed May 9, 2024

- Company: [Lexeo Therapeutics, Inc.](/companies/lxeo.md) (CIK 1907108)
- Form: 8-K
- Filed: 2024-05-09
- Accepted by EDGAR: May 9, 2024, 07:07 ET
- Period: 2024-05-09
- Accession: 0000950170-24-056260
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1907108/000095017024056260/lxeo-20240509.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1907108/000095017024056260/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1907108/000095017024056260/lxeo-20240509.htm

Filed May 9, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-056260. Last ingested by Listed: Nov 5, 2026, 11:18 ET. No prices; not investment advice.